Emerald Foundation Inc
- Assets
- $28.5m
- Revenue
- $1.8m
- Investments
- $26.1m
- Employees
- 0
- Location
- New York, NY
- Founding
- 08/1998
- Data as of
- 12/2021
- EIN
- 13-3912580
Organization Overview
Emerald Foundation Inc is located in New York, NY. The organization was established in 1998. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Emerald Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Emerald Foundation Inc generated $1.8m in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (1.8%) each year. All expenses for the organization totaled $2.2m during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (1.0%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Emerald Foundation Inc has awarded 85 individual grants totaling $10,123,719. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
James P Mahaffey Vice President, Director | 40 | $110,000 | |
Andrew W Heymann President, Director | 8 | $0 | |
Luca Cantelli Director | 0.5 | $0 | |
Robert A Ladislaw Treasurer, Director | 6 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $0 |
| Interest on Savings | $0 |
| Dividends & Interest | $623,228 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $1,177,711 |
| Capital Gain Net Income | $1,177,711 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $1,800,939 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $110,000 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $3,275 |
| Interest | $0 |
| Taxes | $29,192 |
| Depreciation | $0 |
| Occupancy | $120,000 |
| Travel, conferences, and meetings | $917 |
| Printing and publications | $0 |
| Other expenses | $194,091 |
| Total operating and administrative expenses | $817,475 |
| Contributions, gifts, grants paid | $1,425,000 |
| Total expenses and disbursements | $2,242,475 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $164,121 |
| Savings and temporary cash investments | $2,245,529 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $28,512,507 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
Grants Awarded
Over the last fiscal year, Emerald Foundation Inc has awarded $1,425,000 in support to 14 organizations.
| Grant Recipient | Amount |
|---|---|
WEILL CORNELL MEDICINE PURPOSE: TO IDENTIFY REGULATORS OF LINEAGE REVERSION THAT IMPACT RESISTANCE TO WNT-TARGETED THERAPIES IN COLORECTAL CANCER. | $150,000 |
Cambridge, MA PURPOSE: TO INVESTIGATE THE ROLE OF DIET AND NUTRIENT AVAILABILITY IN TUMOR GROWTH, PROGRESSION, AND RESPONSE TO TREATMENT. | $150,000 |
Cambridge, MA PURPOSE: TO ENGANCE NANOPARTICLE ACCUMULATION IN DESIRED CELL TYPES TO DEVELOP MORE EFFECTIVE AND SAFER TARGETED NANOTHERAPIES. | $150,000 |
BRIGHAM AND WOMEN'S HOSPITAL INC PURPOSE: TO UNCOVER AND VALIDATE DRUGGABLE TARGETS THAT CAN BE COMBINED WITH MEK/ERK INHIBITORS TO TREAT RAS PATHWAY-DRIVEN MALIGNANCIES, ESPECIALLY MELANOMA. | $150,000 |
La Jolla, CA PURPOSE: TO INVESTIGATE THE POTENTIAL OF CA19-9 AS A THERAPEUTIC TARGET FOR PANCREATIC CANCER TREATMENT AND TO DISCOVER PHARMACOLOGICAL APPROACHES TO BLOCKING CA19-9 PRODUCTION IN MALIGNANT CELLS. | $100,000 |
Cambridge, MA PURPOSE: TO INVESTIGATE THE ROLE OF TRNA-DERIVED FRAGMENTS AND THE GENES THEY REGULATE IN BREAST CANCER PROGRESSION AND METASTASIS. | $100,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
John R Oishei Foundation Buffalo, NY | $294,151,477 | $18,357,929 |
Lor Foundation Inc West Chester, PA | $352,392,197 | $12,888,892 |
Grable Foundation Pittsburgh, PA | $386,701,292 | $35,946,563 |
Connelly Foundation West Conshohocken, PA | $387,913,026 | $27,891,431 |
American Express Foundation New York, NY | $66,234,265 | $62,922,703 |
Essel Foundation Inc Purchase, NY | $100,106,056 | $12,292,478 |
Beth And Ravenel Curry Foundation New York, NY | $0 | $44,744,046 |
Kz Family Foundation New York, NY | $10,936,301 | $30,139,672 |
The Freeman Foundation P-01644-00-7 New York, NY | $343,405,683 | $35,941,951 |
Hearst Foundation Inc New York, NY | $439,249,947 | $42,040,987 |
Tansy Charitable Foundation New York, NY | $325,076,608 | $77,631,295 |
Gordon & Llura Gund Foundation Princeton, NJ | $18,024,465 | $6,191,436 |